Table 2.
Comparison of the Parameters before and after the Administration of Corticosteroid in Both Groups
| Less advanced LV dysfunction group (n = 17) | Advanced LV dysfunction group (n = 14) | |||||
|---|---|---|---|---|---|---|
| Before | After | P‐value | Before | After | P‐value | |
| Age | 57.9 ±10.2 | ‐ | ‐ | 63.6 ±6.4 | ‐ | ‐ |
| Male | 4 | ‐ | ‐ | 2 | ‐ | ‐ |
| Chest radiographic stage (0/I/II/III) | 5/6/6/0 | ‐ | ‐ | 5/3/4/2 | ‐ | ‐ |
| Skin/eye involvement | 8/2 | ‐ | ‐ | 9/4‐ | ‐ | ‐ |
| Disease duration (months) | 12.5 ±11.7 | ‐ | ‐ | 21.8 ±19.0 | ‐ | ‐ |
| PVC (beats/day) | 1820 ±2969 | 742 ±1425 | 0.048 | 4651 ±8050 | 5794 ±11,538 | 0.280 |
| NSVT | 7/17 | 1/17 | 0.039 | 7/14 | 9/14 | 0.704 |
| CAVB | 8/17 | 4/17 | 0.151 | 4/14 | 4/14 | 1.000 |
| EF (%) | 52.4±13.2* | 55.1±12.2 | 0.060 | 26.2±5.5 | 26.5±7.5 | 0.777 |
| ACE (IU/l) | 17.1±7.1 | 14.4±4.6 | 0.091 | 13.6±8.1 | 11.8±4.6 | 0.196 |
| BNP (pg/ml) | 123.7 ±200.1* | 66.3 ±109.4 | 0.093 | 531.7 ±537.6 | 584.6 ±525.0 | 0.136 |
| Ga uptake | 6/17* | 1/17 | 0.085 | 0/14 | 0/14 | 1.000 |
| CRBBB | 4/17 | 2/17 | 0.656 | 5/14 | 5/14 | 1.000 |
| LP | 5/5 | 2/5 | 0.167 | 4/5 | 4/5 | 1.000 |
Data are given as the mean ±SD and number of patients. *P < 0.05 for comparisons of each value between the less advanced and advanced LV dysfunction groups.